SNPX — Synaptogenix Cashflow Statement
0.000.00%
- $5.54m
- -$20.79m
- 26
- 56
- 57
- 43
Annual cashflow statement for Synaptogenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -15.1 | -12.7 | -12.6 | -5.57 | -6.04 |
Depreciation | |||||
Non-Cash Items | 5.61 | 3.9 | 3.87 | -5.03 | 0.501 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.37 | 0.694 | 0.026 | -0.615 | 0.358 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -11.9 | -8.1 | -8.71 | -11.2 | -5.17 |
Capital Expenditures | -0.005 | -0.005 | -0.003 | -0.007 | -0.003 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | — | -2 |
Purchase of Investments | |||||
Cash from Investing Activities | -0.005 | -0.005 | -0.003 | -0.007 | -2 |
Financing Cash Flow Items | — | -20 | -0.002 | 0 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0.42 | -3.48 | 37.1 | 14.5 | -1.64 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -11.5 | -11.6 | 28.4 | 3.26 | -8.82 |